Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(8%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_4
2
15%
Ph not_applicable
9
69%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(6)
Other(4)

Detailed Status

Completed6
unknown4
Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 42 (15.4%)
N/A9 (69.2%)

Trials by Status

not_yet_recruiting215%
completed646%
recruiting18%
unknown431%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13